Giustina A - Search Results

1

High prevalence of morphometric vertebral fractures opportunistically detected on thoracic radiograms in patients with non-functioning pituitary adenoma.

Frara S, Uygur MM, Bolamperti F, di Filippo L, Doga M, Ferrari F, Losa M, Mortini P, Giustina A. Frara S, et al. Among authors: giustina a. Pituitary. 2024 Aug;27(4):370-380. doi: 10.1007/s11102-024-01394-z. Epub 2024 May 27. Pituitary. 2024. PMID: 38802688

2

Effect of hydrocortisone on the growth hormone response to growth hormone-releasing hormone in acromegaly.

Giustina A, Bussi AR, Doga M, Wehrenberg WB. Giustina A, et al. Horm Res. 1994;41(1):33-7. doi: 10.1159/000183874. Horm Res. 1994. PMID: 8013941

3

Exercise-induced microalbuminuria in patients with active acromegaly: acute effects of slow-release lanreotide, a long-acting somatostatin analog.

Manelli F, Bossoni S, Burattin A, Doga M, Solerte SB, Romanelli G, Giustina A. Manelli F, et al. Among authors: giustina a. Metabolism. 2000 May;49(5):634-9. doi: 10.1016/s0026-0495(00)80040-2. Metabolism. 2000. PMID: 10831175

4

Clinical review 136: Primary lymphoma of the pituitary: an emerging clinical entity.

Giustina A, Gola M, Doga M, Rosei EA. Giustina A, et al. J Clin Endocrinol Metab. 2001 Oct;86(10):4567-75. doi: 10.1210/jcem.86.10.7909. J Clin Endocrinol Metab. 2001. PMID: 11600505 Review. No abstract available.

5

Ectopic secretion of growth hormone-releasing hormone (GHRH) in neuroendocrine tumors: relevant clinical aspects.

Doga M, Bonadonna S, Burattin A, Giustina A. Doga M, et al. Among authors: giustina a. Ann Oncol. 2001;12 Suppl 2:S89-94. doi: 10.1093/annonc/12.suppl_2.s89. Ann Oncol. 2001. PMID: 11762359 Free article. Review.

6

Long-term effects of lanreotide SR and octreotide LAR on tumour shrinkage and GH hypersecretion in patients with previously untreated acromegaly.

Amato G, Mazziotti G, Rotondi M, Iorio S, Doga M, Sorvillo F, Manganella G, Di Salle F, Giustina A, Carella C. Amato G, et al. Among authors: giustina a. Clin Endocrinol (Oxf). 2002 Jan;56(1):65-71. doi: 10.1046/j.0300-0664.2001.01438.x. Clin Endocrinol (Oxf). 2002. PMID: 11849248 Clinical Trial.

7

Efficacy and safety of the new 60-mg formulation of the long-acting somatostatin analog lanreotide in the treatment of acromegaly.

Ambrosio MR, Franceschetti P, Bondanelli M, Doga M, Maffei P, Baldelli R, Tamburrano G, Sicolo N, Giustina A, degli Uberti EC. Ambrosio MR, et al. Among authors: giustina a. Metabolism. 2002 Mar;51(3):387-93. doi: 10.1053/meta.2002.30526. Metabolism. 2002. PMID: 11887179 Clinical Trial.

8

Bisphosphonates in the treatment of glucocorticoid-induced osteoporosis.

Doga M, Bonadonna S, Burattin A, Carpinteri R, Manelli F, Giustina A. Doga M, et al. Among authors: giustina a. Front Horm Res. 2002;30:150-64. doi: 10.1159/000061082. Front Horm Res. 2002. PMID: 11892263 Review. No abstract available.

9

Clinical review: Growth hormone and cardiovascular risk factors.

Gola M, Bonadonna S, Doga M, Giustina A. Gola M, et al. Among authors: giustina a. J Clin Endocrinol Metab. 2005 Mar;90(3):1864-70. doi: 10.1210/jc.2004-0545. Epub 2004 Dec 7. J Clin Endocrinol Metab. 2005. PMID: 15585563 Review.

10

Current guidelines for adult GH replacement.

Doga M, Bonadonna S, Gola M, Solerte SB, Amato G, Carella C, Giustina A. Doga M, et al. Among authors: giustina a. Rev Endocr Metab Disord. 2005 Jan;6(1):63-70. doi: 10.1007/s11154-005-5226-y. Rev Endocr Metab Disord. 2005. PMID: 15711916 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

540 results

Search Page

Filters